Advertisement
Home 2015

Archives

GLP-1 receptor agonists may help reduce cravings and increase satisfaction while eating

ADA: GLP-1 Receptor Agonists May Help Reduce Food Cravings

0
GLP-1 receptors appear to change brain's response to food, researchers say
Scanning maternal plasma cell-free DNA as part of routine noninvasive prenatal testing may also enable presymptomatic detection of maternal tumors

Cancers ID’d With Maternal Plasma Cell-Free DNA Sequencing

0
Sequencing as part of routine noninvasive prenatal testing enables presymptomatic ID of tumors
Melanoma incidence has increased by 253 percent among U.S. children and young adults since the 1970s

ASCO: Melanoma Rates on the Rise for U.S. Youth

0
Women account for two-thirds of cases, likely due to unsafe tanning
Mortality rates among five-year childhood cancer survivors 15 years after diagnosis have been halved since the 1970s -- falling from 12.4 to 6 percent

ASCO: Longevity Improving for Childhood Cancer Survivors

0
Fewer die of 'late effects' from radiation, chemotherapy
Statin use may lower mortality in the weeks and months after coronary artery bypass graft surgery

Statins Found to Improve Outcomes After CABG

0
Patients taking a statin had lower mortality risk in weeks after the surgery, researchers say
The drug elotuzumab reduces the risk of cancer progression and mortality by 30 percent when combined with the standard two-drug therapy for multiple myeloma

ASCO: Elotuzumab Shows Benefit in Multiple Myeloma

0
Survival gains when elotuzumab was added to treatment
Two new targeted treatments have shown promise in slowing the progression of recurring chronic-lymphocytic leukemia and slow-growing non-Hodgkin's lymphoma

ASCO: Rx Strategies Promising for CLL, Non-Hodgkin’s Lymphoma

0
Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma
The first genetic marker to predict response to pembrolizumab (Keytruda) has been identified by researchers

ASCO: MMR Deficiency Predicts Pembrolizumab Response

0
Findings may help doctors better choose patients to receive pembrolizumab (Keytruda)
Targeted radiation in the treatment of brain metastases leads to less cognitive damage than radiation for the entire brain

ASCO: Risks of Whole Brain Radiotx May Outweigh Benefits

0
Second study suggests new immunotherapy may benefit patients with glioblastoma
Changes in bacteria populations may be one reason why people who wear contact lenses are more prone to eye infections

Ocular Bacteria Differ for Contact Lens Wearers

0
Finding may explain why lens wearers are more prone to infection